Serum fructosamine as a screening test for diabetes in the elderly: a pilot study

Area of Science:

• Gerontology
• Endocrinology
• Clinical Chemistry

Background:

• Diabetes mellitus is a significant health concern in the elderly population.
• Early detection of diabetes is crucial for effective management and prevention of complications.

Purpose of the Study:

• To evaluate serum fructosamine as a screening tool for diabetes in older adults.
• To determine the diagnostic accuracy of serum fructosamine for identifying diabetes and impaired glucose tolerance in the elderly.

Main Methods:

• A cross-sectional pilot study was conducted with 157 community-dwelling elderly participants (average age 71.8).
• Serum fructosamine levels were measured using first and second-generation assays.
• A 75-g oral glucose tolerance test (GTT) was administered to subjects without a prior diabetes diagnosis.

Main Results:

• 17% of participants had diabetes mellitus, with 16 being previously undiagnosed and asymptomatic.
• Serum fructosamine levels were significantly higher in asymptomatic diabetics compared to non-diabetics (P < 0.0015 for first-gen, P < 0.0012 for second-gen).
• The second-generation assay showed a sensitivity of 81% and specificity of 87% for detecting diabetes with a cut-point of 250 μMol/L.

Conclusions:

• Serum fructosamine is a promising single-measurement screening test for diabetes in older individuals.
• The test demonstrated utility in identifying asymptomatic diabetes but was less effective for screening impaired glucose tolerance.
• Further validation is warranted to establish its role in routine geriatric diabetes screening.